182 related articles for article (PubMed ID: 15173809)
1. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus.
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fléjou JF
Gastrointest Endosc; 2004 Jun; 59(7):880-9. PubMed ID: 15173809
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus.
Lovat LB; Jamieson NF; Novelli MR; Mosse CA; Selvasekar C; Mackenzie GD; Thorpe SM; Bown SG
Gastrointest Endosc; 2005 Oct; 62(4):617-23. PubMed ID: 16185985
[TBL] [Abstract][Full Text] [Related]
3. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
4. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study.
Javaid B; Watt P; Krasner N
Lasers Med Sci; 2002; 17(1):51-6. PubMed ID: 11845368
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus.
Wolfsen HC
Dig Dis; 2002; 20(1):5-17. PubMed ID: 12145415
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy for Barrett's esophagus: clinical update.
Overholt BF; Panjehpour M
Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
[TBL] [Abstract][Full Text] [Related]
11. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus.
Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY
Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650
[TBL] [Abstract][Full Text] [Related]
13. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy.
Davila ML
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer.
Overholt BF; Panjehpour M
Semin Surg Oncol; 1995; 11(5):372-6. PubMed ID: 7569560
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C
Gastrointest Endosc; 2005 Jul; 62(1):24-30. PubMed ID: 15990815
[TBL] [Abstract][Full Text] [Related]
17. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Wolfsen HC
J Clin Gastroenterol; 2005 Mar; 39(3):189-202. PubMed ID: 15718860
[TBL] [Abstract][Full Text] [Related]
18. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer.
Overholt BF; Panjehpour M
Gastrointest Endosc; 1995 Jul; 42(1):64-70. PubMed ID: 7557181
[No Abstract] [Full Text] [Related]
20. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.
Nava HR; Allamaneni SS; Dougherty TJ; Cooper MT; Tan W; Wilding G; Henderson BW
Lasers Surg Med; 2011 Sep; 43(7):705-12. PubMed ID: 22057498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]